Abiraterone Acetate 250mg Tablets | Abirapro - Glenmark

Advanced Specialty Oncology Care

When addressing specific and complex oncology needs, healthcare providers and patients require treatments that deliver highly precise and reliable results. The Abiraterone Acetate Tablets I.P. (commercially recognized as Abirapro) provide a potent, targeted oral therapy designed to support critical long-term treatment plans. Manufactured by Glenmark, a globally respected leader in pharmaceutical research and manufacturing, these tablets ensure the steady clinical performance necessary for individuals navigating advanced health challenges.

Why Choose Abirapro for Clinical Management?

Managing intensive health conditions often requires strict daily protocol adherence. Instead of relying solely on frequent, invasive clinical visits for treatment administration, patients benefit from Abirapro’s formulated oral tablets, which allow for consistent management from home. Glenmark provides the built-in trust, stringent quality control, and proven efficacy that oncologists, specialized clinics, and leading pharmacies demand when stocking life-saving specialty medications.

Key Product Specifications & Clinical Benefits

Targeted Active Ingredient: Contains premium-grade Abiraterone Acetate I.P. (250 mg per tablet), a highly effective formulation clinically designed for specific specialty oncology care regimens.

Optimized Patient Supply: Conveniently packaged in a bulk bottle containing 120 tablets, ensuring patients have an ample, uninterrupted supply for their ongoing, daily treatment protocols.

Oral Administration: Designed as an easy-to-swallow oral tablet, significantly improving patient compliance and comfort during long-term therapy compared to injectable alternatives.

Hygienic Packaging: The securely sealed bottle protects the sensitive medication from environmental degradation, light, and moisture until the moment of consumption.

Essential Storage & Usage Guidelines Protecting the integrity of this specialized medication is vital for its clinical efficacy. Store the tablets in their original container at room temperature, and protect them strictly from light and moisture.

Important Notice: Abirapro is a Schedule H prescription-only medication. It is dangerous to take this preparation except in accordance with medical advice. It must be prescribed, titrated, and strictly monitored by a Registered Medical Practitioner (typically an oncology specialist). Keep securely out of the reach of children.